News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Calcineurin Inhibitor plus Eltrombopag in reducing transfusion requirements
Yale Cancer Center/X
Dec 11, 2024, 00:01

Calcineurin Inhibitor plus Eltrombopag in reducing transfusion requirements

Yale Cancer Center shared a post on X:

“Jessica M. Stempel and Dr. Nikolai Podoltsev share research demonstrating that Calcineurin Inhibitor plus Eltrombopag is effective in reducing transfusion requirements for patients with acquired Aplastic Anemia.”

Calcineurin Inhibitor

More posts featuring Yale Cancer Center.

acquired Aplastic Anemia anemia Calcineurin Inhibitor cancer Eltrombopag Jessica M. Stempel Nikolai Podoltsev OncoDaily Oncology patients Yale Cancer Center
Special Coverage
Blog
Dec 11, 2024, 00:01
Calcineurin Inhibitor plus Eltrombopag in reducing transfusion requirements
Blog
Dec 10, 2024, 23:59
Talha Badar: PrECOG 0905 Gilt vs Mido in ND FLT3m AML
Blog
Dec 10, 2024, 23:22
Vincent Rajkumar: Myeloma XI / XI+
Blog
Dec 10, 2024, 19:35
New TNM staging system for nasopharyngeal cancer at ESMO Asia
Blog
Dec 10, 2024, 19:32
Optimizing Quality of Survival After Childhood Cancer - Integrative Oncology Working Group
Blog
Dec 10, 2024, 19:27
Herbert Loong: Successful 3 days of education interactions and collaborations building at ESMOAsia24
Blog
Dec 10, 2024, 19:22
Kelly Meza: Meeting with Dr. Ruben A. Mesa at ASH24
Blog
Dec 10, 2024, 19:19
Mohamed Benlazar: CPX-351 vs FLAG-Ida in younger adult patients with AML/MDS and MDS-related gene mutations
Blog
Dec 10, 2024, 19:16
Emanuela Dodeva: A tool to connect, inform, and support survivors across Europe
Blog
Dec 10, 2024, 19:12
Roupen Odabashian: How physicians should start learning?
Blog
Dec 10, 2024, 19:08
Association of European Cancer Leagues is looking for a new Executive Director
Blog
Dec 10, 2024, 19:04
Long-term follow-up of the COMMAND presented by Gullermo Garcia-Manero at ASH24